| WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update D Falzon, E Jaramillo, HJ Schünemann, M Arentz, M Bauer, J Bayona, ... European Respiratory Journal 38 (3), 516-528, 2011 | 789 | 2011 |
| WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems SN Pal, C Duncombe, D Falzon, S Olsson Drug safety 36, 75-81, 2013 | 285 | 2013 |
| Reframing HIV care: putting people at the centre of antiretroviral delivery C Duncombe, S Rosenblum, N Hellmann, C Holmes, L Wilkinson, M Biot, ... Tropical Medicine & International Health 20 (4), 430-447, 2015 | 190 | 2015 |
| Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort WP Law, CJ Duncombe, A Mahanontharit, MA Boyd, K Ruxrungtham, ... Aids 18 (8), 1169-1177, 2004 | 184 | 2004 |
| Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001 WP Law, GJ Dore, CJ Duncombe, A Mahanontharit, MA Boyd, ... Aids 17 (15), 2191-2199, 2003 | 158 | 2003 |
| Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1–infected individuals commencing … A Winston, C Duncombe, PCK Li, JM Gill, SJ Kerr, R Puls, K Petoumenos, ... Clinical infectious diseases 50 (6), 920-929, 2010 | 116 | 2010 |
| Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs J Ananworanich, Z Moor, U Siangphoe, J Chan, P Cardiello, C Duncombe, ... Aids 19 (2), 185-192, 2005 | 111 | 2005 |
| Integrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis AB Suthar, D Hoos, A Beqiri, K Lorenz-Dehne, C McClure, C Duncombe Bulletin of the World Health Organization 91, 46-56, 2013 | 88 | 2013 |
| Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study RL Puls, P Srasuebkul, K Petoumenos, C Boesecke, C Duncombe, ... Clinical infectious diseases 51 (7), 855-864, 2010 | 83 | 2010 |
| Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients D Burger, M Boyd, C Duncombe, M Felderhof, A Mahanontharit, ... Journal of antimicrobial chemotherapy 51 (5), 1231-1238, 2003 | 73 | 2003 |
| The quality of informed consent in a clinical research study in Thailand C Pace, EJ Emanuel, T Chuenyam, C Duncombe, JD Bebchuk, ... IRB: Ethics & Human Research 27 (1), 9-17, 2005 | 70 | 2005 |
| Determinants of HIV drug resistance and public health implications in low-and middle-income countries S Bertagnolio, A De Luca, M Vitoria, S Essajee, M Penazzato, SY Hong, ... Antiviral therapy 17 (6), 941-953, 2012 | 67 | 2012 |
| Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach I Sikazwe, I Eshun-Wilson, K Sikombe, N Czaicki, P Somwe, A Mody, ... PLoS medicine 16 (5), e1002811, 2019 | 57 | 2019 |
| Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals GR Kaufmann, C Duncombe, P Cunningham, A Beveridge, A Carr, ... Aids 12 (13), 1625-1630, 1998 | 56 | 1998 |
| Dynamics of cognitive change in HIV‐infected individuals commencing three different initial antiretroviral regimens: a randomized, controlled study A Winston, R Puls, SJ Kerr, C Duncombe, PCK Li, JM Gill, ... HIV medicine 13 (4), 245-251, 2012 | 53 | 2012 |
| HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting C Duncombe, SJ Kerr, K Ruxrungtham, GJ Dore, MG Law, S Emery, ... Aids 19 (2), 169-178, 2005 | 51 | 2005 |
| Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand R Nuesch, P Srasuebkul, J Ananworanich, K Ruxrungtham, P Phanuphak, ... Journal of antimicrobial chemotherapy 58 (3), 637-644, 2006 | 49 | 2006 |
| Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis K Mayer, B Gazzard, JM Zuniga, KR Amico, J Anderson, Y Azad, G Cairns, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2013 | 46 | 2013 |
| Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year A Imrie, A Carr, C Duncombe, R Finlayson, J Vizzard, M Law, J Kaldor, ... Journal of Infectious Diseases 174 (1), 195-198, 1996 | 41 | 1996 |
| AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment K Falster, JY Choi, B Donovan, C Duncombe, B Mulhall, D Sowden, ... Aids 23 (17), 2323-2336, 2009 | 38 | 2009 |
